Your search returned 119 results.

Results
	1.	Cytochrome P450 in Pharmacogenetics: An Update. [electronic resource] by Tornio, Aleksi Backman, Janne T Producer: 20190718 In: Advances in pharmacology (San Diego, Calif.) vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. [electronic resource] by Tornio, Aleksi Neuvonen, Pertti J Backman, Janne T Producer: 20070109 In: European journal of clinical pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. [electronic resource] by Neuvonen, Pertti J Backman, Janne T Niemi, Mikko Producer: 20081208 In: Clinical pharmacokinetics vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast. [electronic resource] by Karonen, Tiina Neuvonen, Pertti J Backman, Janne T Producer: 20110421 In: European journal of clinical pharmacology vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. [electronic resource] by Neuvonen, Pertti J Niemi, Mikko Backman, Janne T Producer: 20070118 In: Clinical pharmacology and therapeutics vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone. [electronic resource] by Niemi, Mikko Backman, Janne T Neuvonen, Pertti J Producer: 20040930 In: Clinical pharmacology and therapeutics vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast. [electronic resource] by Karonen, Tiina Neuvonen, Pertti J Backman, Janne T Producer: 20120501 In: British journal of clinical pharmacology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine. [electronic resource] by Backman, Janne T Schröder, Marika T Neuvonen, Pertti J Producer: 20080528 In: European journal of clinical pharmacology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. [electronic resource] by Karjalainen, Marjo J Neuvonen, Pertti J Backman, Janne T Producer: 20081112 In: Basic & clinical pharmacology & toxicology vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitors. [electronic resource] by Filppula, Anne M Neuvonen, Pertti J Backman, Janne T Producer: 20150105 In: Drug metabolism and disposition: the biological fate of chemicals vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Effect of itraconazole on the pharmacokinetics of atenolol. [electronic resource] by Lilja, Jari J Backman, Janne T Neuvonen, Pertti J Producer: 20060317 In: Basic & clinical pharmacology & toxicology vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions. [electronic resource] by Karjalainen, Marjo J Neuvonen, Pertti J Backman, Janne T Producer: 20070212 In: Drug metabolism and disposition: the biological fate of chemicals vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects. [electronic resource] by Lilja, Jari J Backman, Janne T Neuvonen, Pertti J Producer: 20050801 In: British journal of clinical pharmacology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine. [electronic resource] by Backman, Janne T Granfors, Marika T Neuvonen, Pertti J Producer: 20070131 In: European journal of clinical pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug Interactions. [electronic resource] by Filppula, Anne M Mustonen, Tiffany M Backman, Janne T Producer: 20190129 In: Basic & clinical pharmacology & toxicology vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo. [electronic resource] by Karjalainen, Marjo J Neuvonen, Pertti J Backman, Janne T Producer: 20080731 In: European journal of clinical pharmacology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation. [electronic resource] by Karjalainen, Marjo J Neuvonen, Pertti J Backman, Janne T Producer: 20080103 In: European journal of clinical pharmacology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing. [electronic resource] by Fanta, Samuel Kinnunen, Mari Backman, Janne T Kalso, Eija Producer: 20151130 In: European journal of clinical pharmacology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. [electronic resource] by Jaakkola, Tiina Laitila, Jouko Neuvonen, Pertti J Backman, Janne T Producer: 20061208 In: Basic & clinical pharmacology & toxicology vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen. [electronic resource] by Tornio, Aleksi Niemi, Mikko Neuvonen, Pertti J Backman, Janne T Producer: 20070809 In: European journal of clinical pharmacology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 119 results.